Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights Mar 30, 2023 04:10PM
Form SC 13G/A Journey Medical Corp Filed by: B. Riley Financial, Inc. Dec 29, 2022 05:15PM
Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position Jul 18, 2022 07:05AM
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference May 23, 2022 08:30AM
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference May 23, 2022 08:30AM


May 16, 2022 08:00AM Entera Bio Board Member, Miranda Toledano, to Assume Role of Chief Business Officer, Chief Financial Officer, and Head of Corporate Strategy
Apr 4, 2022 08:30AM Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
Apr 4, 2022 08:30AM Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
Apr 1, 2022 08:30AM Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Apr 1, 2022 08:30AM Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Feb 11, 2022 05:25PM Form SC 13G Journey Medical Corp Filed by: B. Riley Financial, Inc.
Nov 29, 2021 08:00AM Journey Medical Corporation Introduces Expanded Board of Directors
Nov 16, 2021 04:01PM Journey Medical Corporation Announces Closing of Initial Public Offering
Nov 16, 2021 04:01PM Journey Medical Corporation Announces Closing of Initial Public Offering
Nov 12, 2021 10:57AM Journey Medical (DERM) IPO Opens 13% Lower
Nov 12, 2021 07:01AM Journey Medical Corp (DERM) Prices 3.52M Share IPO at $10/sh
Nov 12, 2021 07:00AM Journey Medical Corporation Prices $35.2 Million Initial Public Offering
Nov 12, 2021 07:00AM Journey Medical Corporation Prices $35.2 Million Initial Public Offering
Nov 8, 2021 10:12AM Journey Medical Corporation Announces Launch of its Initial Public Offering
Oct 22, 2021 04:08PM Journey Medical Corp (DERM) Files IPO Registration Statement